Company Description
Dendreon wants to boost your immunity from the start. It is developing therapeutic vaccines that goose the body's immune system to help it fight...
Key Dendreon Financials
| Company Type | Public - NASDAQ (GM): DNDN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $0.7 |
| 2005 Employees | 208 |
More Dendreon Financials (11 pages)
Latest Dendreon Jobs jobs by Indeed
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Dendreon's competition across multiple industries
Top Dendreon Competitors
Sponsored Links
The Business Directory
Dendreon Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Richard B. Brewer | Network | E-mail |
| President, CEO, and Director | Mitchell H. Gold | Network | E-mail |
| SVP and CFO | Gregory T. (Greg) Schiffman | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Dendreon News
- SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY [European Patents] (11 Nov 2008 13:41:00 EST)
- FirstAlert: 8-9:55 A.M. Investrend / Bestcalls [InvesTrend] (11 Nov 2008 00:01:00 EST)
- Dendreon Corporation (DNDN) Corporate Event Announcement Notice [Wall Street Horizon] (08 Nov 2008 20:48:00 EST)
Sponsored Opportunity
